Company

Validose Inc.

Validose develops smart-dose technology to support patient adherence in clinical trials.

About

Validose develops smart-dose technology that combines patient data with an API for monitoring adherence in clinical trials. Its system supports personalized coaching and real-time interventions and can operate independently or integrate with existing systems. Founded in 2017, the company is based in Brooklyn, US. In December 2024, it raised USD 1.6 mn in funding led by Peter Bauer’s Family Office, with Interstate Fusion Ventures and 10XBeta participating.

2Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in